SCIENCE TO CONSUMERS, INC. Inactive Instrument
Science to Consumers, Inc. Share Price Other OTC
Equities
BEUT
US8086451056
Personal Products
| Sales 2015 | - | Sales 2016 | - | Capitalization | 6.62M 528M |
|---|---|---|---|---|---|
| Net income 2015 | - 0 | Net income 2016 | - 0 | EV / Sales 2015 | - |
| Net Debt 2015 | 7.14K 569K | Net Debt 2016 | 36.58K 2.92M | EV / Sales 2016 | - |
| P/E ratio 2015 |
-250
x | P/E ratio 2016 |
-109
x | Employees | - |
| Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 34.21% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Edwon Lam
CEO | Chief Executive Officer | - | 17/08/15 |
Bryan Glass
PSD | President | - | - |
| Corporate Secretary | 43 | 14/04/13 |
Science to Consumers, Inc. is a development stage company. The Company is focused on the distribution of Argan oil and Argan oil products to stores, spas, massage therapy offices and individuals in Germany. The Company is focused on marketing and selling DermLastyl anti-aging skin care products. The Company sells approximately six products that are available to be purchased through its Website and wholesale orders. The Company sells various products, which include Dermalastyl Facial Scrub, Dermalastyl Bx Pro, Dermalastyl Bx Elastropin, Dermalastyl-e Intensive Eye Serum, Dermalastyl-m Wrinkle Eye Radicator, Dermalastyl-m Anti- Wrinkle after shave for Men. Its products are marketed in China, Hong Kong, and Germany, and it also plans to expand to other European markets. The Company has not generated any revenue from its operations.
Sector
Personal Products
| 1st Jan change | Capi. | |
|---|---|---|
| -2.16% | 250B | |
| +12.81% | 19.77B | |
| 0.00% | 17.89B | |
| +0.38% | 11.09B | |
| +16.34% | 7.75B | |
| +10.15% | 5.97B | |
| +1.54% | 4.52B | |
| -18.03% | 3.8B | |
| -5.56% | 3.45B |
